Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2023 March Clinical practice Clinical efficacy of non-pharmacological therapy for sickle cell disease and oncologic conditi... Read more
2023 February Science Amsterdam scientists investigate why immunotherapy fails in Chronic Lymphocytic Leukaemia Read more
2023 February Pharma News Pirtobrutinib gets FDA approval for relapsed or refractory mantle cell lymphoma Read more
2022 October Clinical trials Novel CAR T-cell therapy GPRC5D shows promise in treatment of multiple myeloma Read more
2022 September Science High medical costs associated with lifetime treatment of sickle cell disease Read more